Abionic received CE marking for the IVD Capsule PSP test in early 2017 and EU IVDR certification in mid-2022. The test is being developed for the Chinese market by Fapon under an exclusive license ...
The solution will use Owkin's data network and artificial intelligence to pre-screen for gBRCA mutations in breast cancer directly from digital pathology slides.
Some results have been hidden because they may be inaccessible to you